Alnylam Pharmaceuticals Inc (ALNY)
273.91
+7.32
(+2.75%)
USD |
NASDAQ |
Nov 01, 16:00
273.75
-0.16
(-0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price to Book Value: 1091.96 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1091.96 |
| October 31, 2024 | 1062.77 |
| October 30, 2024 | 1122.17 |
| October 29, 2024 | 1134.93 |
| October 28, 2024 | 1143.78 |
| October 25, 2024 | 1135.61 |
| October 24, 2024 | 1169.54 |
| October 23, 2024 | 1174.24 |
| October 22, 2024 | 1180.65 |
| October 21, 2024 | 1162.85 |
| October 18, 2024 | 1178.46 |
| October 17, 2024 | 1181.73 |
| October 16, 2024 | 1196.86 |
| October 15, 2024 | 1144.33 |
| October 14, 2024 | 1128.24 |
| October 11, 2024 | 1132.23 |
| October 10, 2024 | 1109.53 |
| October 09, 2024 | 1078.79 |
| October 08, 2024 | 1079.94 |
| October 07, 2024 | 1062.34 |
| October 04, 2024 | 1067.20 |
| October 03, 2024 | 1073.33 |
| October 02, 2024 | 1081.37 |
| October 01, 2024 | 1099.33 |
| September 30, 2024 | 1095.23 |
| Date | Value |
|---|---|
| September 27, 2024 | |
| September 26, 2024 | |
| September 25, 2024 | |
| September 24, 2024 | |
| September 23, 2024 | |
| September 20, 2024 | |
| September 19, 2024 | |
| September 18, 2024 | |
| September 17, 2024 | |
| September 16, 2024 | |
| September 13, 2024 | |
| September 12, 2024 | |
| September 11, 2024 | |
| September 10, 2024 | |
| September 09, 2024 | |
| September 06, 2024 | |
| September 05, 2024 | |
| September 04, 2024 | |
| September 03, 2024 | |
| August 30, 2024 | |
| August 29, 2024 | |
| August 28, 2024 | |
| August 27, 2024 | |
| August 26, 2024 | |
| August 23, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
6.276
Minimum
Nov 14 2019
1196.86
Maximum
Oct 16 2024
65.91
Average
18.18
Median
Feb 04 2021
Price to Book Value Benchmarks
| Pfizer Inc | 1.815 |
| Regeneron Pharmaceuticals Inc | 3.161 |
| BridgeBio Pharma Inc | -- |
| Biomarin Pharmaceutical Inc | 2.345 |
| Johnson & Johnson | 5.495 |
Price to Book Value Related Metrics
| PS Ratio | 16.58 |
| Price to Free Cash Flow | 2161.73 |
| Price | 273.91 |
| Earnings Yield | -0.96% |
| Market Cap | 35.33B |